Other less well-characterized relationships exist for the other RecQ family members with RECQL1, RECQL4 and BLM being significantly overexpressed in various cancers [80–82], with high expression generally being linked to poor prognosis, and depletion causing a reduction in proliferation and chemosensitization. The gene discussed is BLM; the disease is cancer.